CD39/CD73-mediated immunosuppression and tumor aggressiveness in bladder cancer.

Saved in:
Bibliographic Details
Title: CD39/CD73-mediated immunosuppression and tumor aggressiveness in bladder cancer.
Authors: Furriel F; Faculty of Medicine, University of Coimbra (FMUC), Coimbra, Portugal.; Unidade Local de Saúde Região de Leiria, Department of Urology, Hospital Santo André, Leiria, Portugal.; Department of Urology, CUF Coimbra Hospital, Coimbra, Portugal.; Faculty of Medicine (FMUC), Coimbra Institute for Clinical and Biomedical Research (iCBR), University of Coimbra, Coimbra, Portugal., Laranjeira P; Flow Cytometry Unit, Clinical Pathology Department, Hospitais da Universidade de Coimbra, Unidade Local de Saúde de Coimbra, Coimbra, Portugal.; CIBB-Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.; Faculty of Medicine (FMUC), Coimbra Institute for Clinical and Biomedical Research (iCBR), University of Coimbra, Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal., Pereira M; Flow Cytometry Unit, Clinical Pathology Department, Hospitais da Universidade de Coimbra, Unidade Local de Saúde de Coimbra, Coimbra, Portugal., Silva S; Flow Cytometry Unit, Clinical Pathology Department, Hospitais da Universidade de Coimbra, Unidade Local de Saúde de Coimbra, Coimbra, Portugal., Silva I; Flow Cytometry Unit, Clinical Pathology Department, Hospitais da Universidade de Coimbra, Unidade Local de Saúde de Coimbra, Coimbra, Portugal., Fontinha G; Unidade Local de Saúde de Coimbra, Department of Pathology, Hospitais da Universidade de Coimbra, Coimbra, Portugal., Sousa V; Faculty of Medicine, University of Coimbra (FMUC), Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal.; Unidade Local de Saúde de Coimbra, Department of Pathology, Hospitais da Universidade de Coimbra, Coimbra, Portugal., Gomes C; CIBB-Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.; Faculty of Medicine (FMUC), Coimbra Institute for Clinical and Biomedical Research (iCBR), University of Coimbra, Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal., Parada B; CIBB-Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal. parada.belmiro@gmail.com.; Faculty of Medicine (FMUC), Coimbra Institute for Clinical and Biomedical Research (iCBR), University of Coimbra, Coimbra, Portugal. parada.belmiro@gmail.com.; Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal. parada.belmiro@gmail.com.; Unidade Local de Saúde de Coimbra, Department of Urology and Renal Transplantation, Hospitais da Universidade de Coimbra, Coimbra, Portugal. parada.belmiro@gmail.com., Paiva A; Flow Cytometry Unit, Clinical Pathology Department, Hospitais da Universidade de Coimbra, Unidade Local de Saúde de Coimbra, Coimbra, Portugal.; CIBB-Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.; Faculty of Medicine (FMUC), Coimbra Institute for Clinical and Biomedical Research (iCBR), University of Coimbra, Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal.; Ciências Biomédicas Laboratoriais, ESTESC-Coimbra Health School, Instituto Politécnico de Coimbra, Coimbra, Portugal.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Apr 22; Vol. 75 (5). Date of Electronic Publication: 2026 Apr 22.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first